Researchers have been excited about the medication , a innovative dual agonist showing remarkable results in early trials for weight reduction . It acts by modulating several systems: GLP-1 and GIP, which https://caoimhezaqr032177.webbuzzfeed.com/41114945/this-new-possibility-for-weight-reduction